Fulltext

No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy

Valko, P. ; Khatami, R. ; Baumann, C. ; Bassetti, C.

In: Journal of Neurology, 2008, vol. 255, no. 12, p. 1900-1903

Add to personal list
    Title
    • No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy
    Author
    • Valko, P.. Dept. of Neurology, University Hospital of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland
    • Khatami, R.. Dept. of Neurology, University Hospital of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland
    • Baumann, C.. Dept. of Neurology, University Hospital of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland
    • Bassetti, C.. Dept. of Neurology, University Hospital of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland
    Document Type
    • Postprint
    OAI-PMH Identifier
    • oai:doc.rero.ch:315167
    Summary
    We report on four patients with narcolepsy with cataplexy (NC), who were treated with high-dose intravenous immunoglobulins (IVIg). Although in some patients transient effects were seen of both objective (multiple sleep latency test and maintenance of wakefulness test) and subjective symptoms (Epworth Sleepiness Scale and frequency of cataplexy), these effects lasted at the most for a few weeks and did not persist. Our report challenges the recent observations of a favorable and persistent effect of IVIg in NC patients